KORU Medical forecasts 2026 revenue of $47.5 million-$48.5 million

• KORU Medical forecast FY 2026 revenue of $47.5-$48.5 million, implying 15-18% year-on-year growth.
• Gross margin outlook lifted to 62-64% from 61-63%, citing pricing actions, manufacturing efficiencies, a new supplier contract.
• Expectations include positive adjusted EBITDA, year-end cash above $7.5 million; Q3 seen as the heaviest cash-usage quarter.
• FY 2025 revenue was $41.1 million; cash balance was $8.3 million as of the Q2 2026 earnings release.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KORU Medical Systems Inc. published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.